Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Tg Therapeutics (TGTX) over the last 7 years, with Q3 2025 value amounting to 0.24.

  • Tg Therapeutics' Debt Ratio fell 4255.25% to 0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24, marking a year-over-year decrease of 4255.25%. This contributed to the annual value of 0.42 for FY2024, which is 3928.87% up from last year.
  • As of Q3 2025, Tg Therapeutics' Debt Ratio stood at 0.24, which was down 4255.25% from 0.35 recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Debt Ratio registered a high of 0.49 during Q1 2023, and its lowest value of 0.04 during Q3 2021.
  • For the 5-year period, Tg Therapeutics' Debt Ratio averaged around 0.28, with its median value being 0.3 (2023).
  • As far as peak fluctuations go, Tg Therapeutics' Debt Ratio crashed by 8084.95% in 2021, and later surged by 73599.44% in 2022.
  • Quarter analysis of 5 years shows Tg Therapeutics' Debt Ratio stood at 0.18 in 2021, then surged by 105.88% to 0.37 in 2022, then dropped by 17.34% to 0.3 in 2023, then surged by 39.29% to 0.42 in 2024, then tumbled by 43.43% to 0.24 in 2025.
  • Its Debt Ratio was 0.24 in Q3 2025, compared to 0.35 in Q2 2025 and 0.37 in Q1 2025.